P04.1: Newborn affected by other maternal medication codeFirst withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1) excludes1 dysmorphism due to warfarin (Q86.2) fetal hydantoin syndrome (Q86.1) excludes2 maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0) maternal use of drugs of addiction (P04.4-) |
| P04.11: Newborn affected by maternal antineoplastic chemotherapy |
| P04.12: Newborn affected by maternal cytotoxic drugs |
| P04.13: Newborn affected by maternal use of anticonvulsants |
| P04.14: Newborn affected by maternal use of opiates |
| P04.15: Newborn affected by maternal use of antidepressants |
| P04.16: Newborn affected by maternal use of amphetamines |
| P04.17: Newborn affected by maternal use of sedative-hypnotics |
| P04.1A: Newborn affected by maternal use of anxiolytics |
| P04.18: Newborn affected by other maternal medication |
| P04.19: Newborn affected by maternal use of unspecified medication |